Get documents about "Opening Research Scientist Bioinformatics
Description
Opening Research Scientist Bioinformatics document sample
Document Sample
Bioinformatics
Conference 2010
Enhancing synergy among life sciences and information technology
17th – 18th May 2010, BSG House, London, UK BOOK NOW!
Key Speakers
Josef Scheiber, Computational Biologist, Roche Diagnostics
Dr. Abdelazize Laoui, Director Drug Design, Sanofi-Aventis
Christopher Southan, Contractor, AstraZeneca
Dr. Jonathan Green, Head of Bioinformatics Unit, Health Protection Agency
Sandeep Modi, Cheminformatics, Unilever
Chris Rawlings, Head of Biomathematics and Bioinformatics, Rothamsted Research
Dr. Tatiana Tatarinova, Senior Lecturer Statistics, University of Glamorgan
Rob Gill, Director, AnurOS
Burkhard Schaefer, President, BSSN Software
Dr. Meeta Rani Mannaert, Chief Research Officer, HPC Project, University of Pecs
Driving the Industry Forward | www.futurepharmaus.com
Media Partners
To Book Call: +91-022-27578668 | http://www.bharatbook.com
Conference Introduction
Bioinformatics Conference 2010
17th – 18th May 2010, London, UK
Dear Colleague, Media Partners:
According to BCC Research ‘The worldwide value of bioinformatics is expected to PharmiWeb.com is the leading industry-sponsored portal for
grow to $3.0 billion in 2010, at an average annual growth rate of 15.8%.’ the pharmaceutical sector. Supported by most of the leading
In recent years there has been an explosive growth in biological data which has pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features,
to be managed and stored for various purposes. Bioinformatics plays a vital role in events listings and international jobs to industry professionals across Europe and the US.
developing new tools for managing and analysing the data. For further information please email: corporate@pharmiweb.com
The bioinformatics market is driven by the need of pharmaceutical BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD.
and biotechnology companies to increase the efficiency of their It is based and located in Warsaw, Poland. Biotechnology World was
drug-discovery and development efforts. The focus is now on target validation founded in 2007 to provide the world’s biotech and pharma information and market to
for translating genomic information into knowledge for developing therapeutics, make it universally accessible and useful for scientific and business processes. Its first step
proteomics and the changing trends in the drug discovery procedures. to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will
allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers
Bioinformatics conference will provide an ideal platform for the attendees companies completed internet public relations, publication and marketing solutions. One of
to get an overview of the recent advances and challenges in this area, and provide a the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector
novel outlook on emerging technologies and next generation business models. in Europe to global biotechnology, pharmaceutical and life science activities.
For further information please visit www.biotechnology-europe.com
Key Benefits:
Future Pharmaceuticals has forged powerful relationships with
Driving the Industry Forward | www.futurepharmaus.com
• Examine DNA and RNA structure, function and sequence analysis key industry leaders to provide a platform for successful brand
• Assess the challenges of data integration recognition, and for senior decision-makers to have the means to procure and plan
• Evaluate the advantages of proteomic analysis to the drug industry implementation strategies based on the topics covered. Positioned to be an authoritative
• Analyse the future regulatory environment resource within top pharma companies as well as small, specialty, and biotech, Future
Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted
• Receive an update on the global informatics software market
and responsive audience, bridging the gap between the industries’ top issues and the
• Gain an insight into the bioinformatics application in drug discovery solutions top-tier vendors can provide.
• Be part of a unique networking opportunity For further information please visit: www.futurepharmaus.com
I look forward to meeting you at the conference InPharm is the online platform for exclusive pharmaceutical news,
comment, contracts, services, jobs and events and is home to
Best regards InPharmjobs.com, Pharmafile and Pharmafocus.
For further information please visit: www.In-Pharm.com
‘Pharma Connections Worldwide® is the leading professional
business networking website focused in the Pharmaceutical,
Pranita Nangia
Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for
Conference Producer
delivery of premiere content coupled with the right clientele in order to facilitate business
development opportunities among industry professionals responsible for making key
decisions in a global marketplace. ‘
Who should attend? For further information please visit: www.pharmaconnections.com
VPs, Directors, Heads and • Regulatory Affairs
Managers of:
• Scientific Affairs
• Health Informatics
• Legal
• Medical Informatics
• Intellectual Property
• Bioinformatics
• Process Development
• Biostatistics
• Process Engineering
• Biocomputing
• Validation
• Bio Research
• Technical Management
• Bio IT
• Pharmaceutical
• Clinical Trial Technology
• Scientific Data • Analytical Research,
Scientist,
• Bioanalytical
• Marketing Sponsorship and exhibition opportunities:
• Chemoinformatics
• Sales This event offers a unique opportunity to meet and do business with some
• Lead Discovery
of the key players in the pharmaceutical and biotech industries. If you have a
• Product Management
• Genetics service or product to promote, you can do so at this event by:
• Business Development
• Biochemistry • Hosting a networking drinks reception
• Computational Chemistry Others • Taking an exhibition space at the conference
• Computer Assisted • Scientists • Advertising in the delegate documentation pack
Drug Design
• Biologists • Providing branded bags, pens, gifts, etc.
• Data Mining If you would like more information on the range of sponsorship or exhibition
• Physicists
• Molecular biology possibilities for Immunogenicity Summit, Please contact us:
• Academics
• Molecular Medicine S. Raju +91-022-27578668
• Researchers
• Drug Safety info@bharatbook.com
Day 1
Bioinformatics Conference 2010
Monday 17th May 2010, London, UK
09:30 Registration and refreshments 13:10 Networking lunch
10:00 Opening address from the chair 14:30 Era of Science 2.0
• Using social web by scientists, open source, open data and
workflow technologies
10:10 Analysing networks in biology – What data do we
• New digital tools and artefacts
need for sophisticated analyses and why?
• Potential of Web2.0 tools for science
• Properties of biological networks
• Overview on information we need
15:10 Cloud computing and its opportunities/challenges
• Overview on available information
with bioinformatics
• What can we do with that?
• Estimating value of cloud computing
• Examples
• Security and compliance requirements
• Future directions
• Critical considerations for developing applications
Josef Scheiber
Computational Biologist
Roche Diagnostics 15:50 Afternoon refreshments
10:50 Assess the challenges of data integration
16:10 A paradigm to explain development of metabolic
• Importance of data integration disorders/diseases
• Current challenges for data integration • A general explanation of the molecular mechanism and pathway of
diseases by any simple and universal paradigm is still a daunting task in this
• Possible solutions / limitations
millennium characterised by high throughput biomolecular data production
• Show application of these using cheminformatic models in genetix and high performance computing fortified with efficient algorithms
toxicology area
• What could be the cause of these newly emerging diseases?
Sandeep Modi
• Propose a simple theory of cause of metabolic diseases. In this paradigm
Cheminformatician
it will be possible to predict new diseases and also explain the inter-
Unilever
relationships between apparently distinct diseases
Dr. Meeta Rani Mannaert
11:30 Morning refreshments Chief Research Officer, HPC Project,
University of Pecs
11:50 Assessing the complementarities of databases 16:50 Biodiveristy informatics component-strategic
that integrate data between drug targets and objectives and perspectives
bioactive compounds
• Analysing trends in biodiversity information management
• Content overlap provides useful insights
• Assessment of completeness of biodiversity data
• The expansion of data-integrated bioactive space relevant to drug
discovery and chemical biology • Advancements made so far
• Both commercial and public sources are complementary for its exploration
Christopher Southan 17:30 Closing remarks from the chair
Contractor, AstraZeneca
Special Professor of Proteomics,
University of Nottingham, Biosciences
17:40 Networking drinks
Take your discussions further and build new
relationships in a relaxed and informal setting
12:30 Examine DNA and RNA structure, function and
sequence analysis
Day 2
Bioinformatics Conference 2010
Tuesday 18th May 2010, London, UK
09:30 Registration and refreshments 13:10 Networking lunch
10:00 Opening address from the chair
14:30 Data integration and bioinformatics – problems
10:10 Healthcare informatics challenges for an aging society and solutions
• Pharmaceutical company moving towards global healthcare corporation • Contemporary biological research relies on access to data from many
• Healthcare paradigm shift from traditional inpatient care towards different resources
home-based care
• The automatic integration of biological data is challenging because of the
• Develop solutions that span from wellness to illness care scale and heterogeneity of the available data
• Role of informatics to enable a consumer healthcare business model
• Provide an overview of a general-purpose data integration platform (Ondex)
• Vision-Gain from a true integrated and diversified healthcare system that has been developed by Rothamsted Research and collaborators
Dr. Adel Laoui • Ondex combines data integration, data visualisation and analysis methods
Director Delivery, Devices and e-Healthcare Technologies that facilitate working with large scale biological networks (e.g. of genes,
Sanofi-Aventis proteins, biochemical pathways etc)
• Illustrations will be provided of the how Ondex has been used to
10:50 Bioinformatics for public health microbiology
overcome data integration problems and how integrated analysis of
• The ‘research to surveillance’ informatics continuum biological networks has revealed novel biological discoveries
• Communicating and translating data into ‘information for action’
Prof. Chris Rawlings
• Data integration needs and challenges for infectious disease management
Scientific Director of Centre for Mathematical and Computational
and control
Biology and Head of Department of Biomathematics and Bioinformatics
• Looking forward – the impact of new technologies Rothamsted Research
Dr. Jon Green
Head of Bioinformatics Unit
Health Protection Agency 15:10 Processing and archiving experiment data with the
AnIML data standard
11:30 Morning refreshments
• A look at the current state of laboratory and bioinformatics
• Introduction to the AnIML standard for analytical data
11:50 A unifying theory for GC3 biology in plants and animals
• Two kinds of genes in plants and animals • Using generic software components to streamline working with analytical data
• Most probable explanations for GC3 bimodality • Making it easier to exchange data from different instruments
• Role of biased gene conversion • Long-term archiving of laboratory data
• Transcriptional advantage of high GC3
Burkhard Schaefer
• Effects of gene methylation in biological systems
President
• Applications of GC3 for functional genome annotation BSSN Software
Dr Tatiana Tatarinova
Senior Lecturer in Statistics
University of Glamorgan 15:50 Afternoon refreshments
12:30 Bioinformatics, integration, virtualisation and “Elastic
Computing”. A new way to run your analysis pipelines? 16:10 Analysing the future regulatory environment
• Data management and analysis is becoming more expensive
• Data volumes continue to increase with new technology and will continue
to do so 16:50 Chair’s closing remarks
• Hardware and support are largely “Hidden” costs
• Pharma and biotech and constantly looking for ways to streamline their
organisations and save money 17:00 End of Conference
• Flexibility Vs IT process
• Can outsourcing and virtualisation help?
Rob Gill
Director
AnurOS
